Dalmia Bharat Sugar and Industries Ltd Q4 Results: Stocks soar to a 5-month high of ₹464.90 amid robust profit growth of 126%

As of 14th May 2025, Dalmia Bharat Sugar Industries shares opened at ₹464.50, 12% higher than the previous closing of ₹414.00. On the closing bell, the share price closed at ₹449.00 with closing gains of 8.45%. The Dalmia Bharat Sugar Industries share price rally can be attributed to the positive sentiment fuelled by robust growth in the company’s Q4FY25 profits and revenue. 

Dalmia Bharat Sugar Limited Q4 Results 2025: Key Highlights

1. Dalmia Bharat Sugar and Industries Ltd revenue from operations in Q4FY25 stood at ₹1,017.87 crores, registering an increase of 35.07% compared to the corresponding period of the previous year. 
2. On the profit front, the company’s net profit for Q4FY25 climbed to ₹206.32 crores, reflecting a whopping surge of 126% compared to ₹91.32 crores of Q4FY24. 
3. The reported EBITDA of Dalmia Bharat Sugar Limited for the quarter ended March 2025 increased to ₹195 crores, 65.31% higher than ₹118 crores in Q4FY24. 
4. The basic and diluted earnings per share (EPS) of the company decreased to 25.49 from 47.78 in the corresponding quarter of FY24.
5. The sugar segment of Dalmia Sugar Limited earned the highest revenue of 878.34 crores in Q4FY25, reflecting an increase from the revenue of ₹663.02 crores in Q4FY24. 
6. Dalmia Bharat Sugars and Industries’ exports revenue for Q4FY25 stood at a figure of ₹55.19 crores.

Conclusion

Dalmia Bharat Sugar’s share saw a significant price surge during the trading on 14 May 2025. The share opened with gains of approximately 12% with an opening price of ₹456.60. Such a price increase reflects the positive sentiment of investors due to the strong profit and revenue growth of the company. In Dalmi Bharat Sugars Q4 results 2025, a growth of 126% in profits, along with 35% revenue growth. The robust profitability of the company is a result of high average sales realisation, increased ethanol production, and the addition of export revenues. 

For regular stock updates, dividend alerts, and expert verdicts, stay informed with Univest!

Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities. 

Recent News Articles 

Accretion Pharmaceuticals IPO GMP: Day 1 IPO Live Updates

Stock Market Today: Sensex Trades 350 Points Up; Nifty50 Jumps 0.46%

Stocks to Watch Today: 14th May 2025

Other News Articles

Accretion Pharmaceuticals IPO GMP & Review

RVNL Share surges 8% on Order Win Despite Weak Technics

Integrity Infrabuild Developers IPO GMP: Day 1

Sensex Trades 800 Points Down; Nifty50 Plunged 0.75%:

Stocks to Watch Today: 13th May 2025

Trent Ltd. Share Surges 4.5% Despite Dull Q4 Performance